Form 4: Carlyle Group Sells QuidelOrtho Corp Shares in Multiple Transactions
SEC Form 4
The Carlyle Group executed multiple sales of QuidelOrtho Corp shares between July 22 and July 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- The Carlyle Group, a significant shareholder of QuidelOrtho Corp, has sold a portion of its holdings.
- The sales occurred on July 22 and July 23, 2024.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
- The sales involved multiple transactions at varying prices.
- On July 22, 2024, 6,202 shares were sold at a weighted average price of $34.9597, with prices ranging from $34.8854 to $34.9961.
- Also on July 22, 2024, 129,039 shares were sold at a weighted average price of $35.3292, with prices ranging from $35.00 to $35.7493.
- On July 23, 2024, 8,814 shares were sold at a weighted average price of $35.5778, with prices ranging from $35.125 to $35.9993.
- Also on July 23, 2024, 84,892 shares were sold at a weighted average price of $36.5844, with prices ranging from $36.00 to $36.9995.
- Finally on July 23, 2024, 5,839 shares were sold at a weighted average price of $37.0242, with prices ranging from $37.00 to $37.07.
- Following these transactions, Carlyle Partners VI Cayman Holdings, L.P. still holds 10,327,772 shares indirectly.
Sentiment
Score: 5
Explanation: Neutral sentiment as it simply reports transactions. The sales themselves don't necessarily indicate a positive or negative outlook, but rather adherence to a pre-arranged plan.
Risks
- Continued sales by Carlyle Group could exert downward pressure on QuidelOrtho Corp's stock price.
Future Outlook
The document does not provide any specific future outlook for QuidelOrtho Corp.
Industry Context
This Form 4 filing indicates activity by a major shareholder, which is a common occurrence. Monitoring such filings can provide insights into the sentiment and strategies of significant investors.
Stakeholder Impact
- The share sales could potentially impact shareholder value, depending on market reaction.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| 07/22/2024 | Date of first reported transaction. |
| 07/23/2024 | Date of last reported transaction. |
| 07/24/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.